COVID-19 Associated Myocarditis: Prevalence, Pathophysiology, Diagnosis, and Management

Ji Yan1,2, Jiang Hong1

  • 1From the Department of Internal and Emergency Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Cardiology in Review
|August 22, 2023
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause COVID-19, leading to myocarditis. This study explores the cardiovascular complications of COVID-19, including diagnosis and treatment.

Area of Science:

  • Cardiology
  • Virology
  • Immunology

Background:

  • COVID-19, caused by SARS-CoV-2, significantly impacts global public health.
  • While primarily a respiratory illness, COVID-19 also affects other organs, notably the cardiovascular system.
  • Myocarditis is a serious complication of COVID-19 with potentially adverse outcomes.

Purpose of the Study:

  • To investigate the mechanisms behind COVID-19-induced myocarditis.
  • To review the clinical manifestations and diagnostic approaches for COVID-19 myocarditis.
  • To compare COVID-19 myocarditis with other forms of viral myocarditis.

Main Methods:

  • Review of existing literature on COVID-19 and cardiovascular complications.
  • Analysis of clinical data including cardiac biomarkers, ECG, echocardiography, and cardiac MRI.
  • Discussion of endomyocardial biopsy as a diagnostic tool.

Main Results:

  • Elevated cardiac biomarkers, ECG abnormalities, and impaired cardiac function are key indicators.
  • Angiotensin-Converting Enzyme2 (ACE2) plays a role in SARS-CoV-2 infection.
  • Immune overresponse and potentially direct viral injury contribute to myocardial damage.

Conclusions:

  • COVID-19 myocarditis is a significant concern requiring thorough diagnostic evaluation.
  • Understanding the pathogenesis is crucial for effective treatment strategies.
  • Further research is needed to fully elucidate the role of direct viral injury.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20